Back to Search Start Over

Organizing pneumonia and COVID-19.

Authors :
Tonon CR
Tanni SE
Rocha J
Godoy I
Polegato BF
Pereira FWL
Martins D
Prudente RA
Franco ET
Brizola F
Baldi BG
Okoshi MP
Source :
The American journal of the medical sciences [Am J Med Sci] 2023 Dec; Vol. 366 (6), pp. 458-463. Date of Electronic Publication: 2023 Sep 30.
Publication Year :
2023

Abstract

Organizing pneumonia (OP) is an interstitial lung disease, and can be cryptogenic, if no cause is identified, or secondary to several conditions. COVID-19-induced persistent inflammation can be associated with interstitial lung disease. We present a review of literature of OP and COVID-19-induced OP with an illustrative case. A 38-year-old man was admitted with COVID-19 that required mechanical ventilation for 56 days. Initial chest computed tomography (CT) revealed diffuse bilateral ground-glass opacities in the lungs with consolidation areas involving 75 % of the parenchyma. After weaning from MV, the patient still required oxygen supplementation. A new chest CT scan also showed extensive diffuse areas of consolidation and ground-glass opacity. OP was hypothesized and 40 mg/day prednisone initiated and continued for six months with resolution of lung functional and image abnormalities. Organizing pneumonia should be included in the differential diagnosis of COVID-19 patients with respiratory symptoms after partial pulmonary recovery.<br />Competing Interests: Declaration of Competing Interest The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1538-2990
Volume :
366
Issue :
6
Database :
MEDLINE
Journal :
The American journal of the medical sciences
Publication Type :
Academic Journal
Accession number :
37778722
Full Text :
https://doi.org/10.1016/j.amjms.2023.09.023